Other ways to give

Not into running marathons or climbing Everest? No problem; there are plenty of other ways you can support Ataxia UK!

Remembering a loved one Read more

Remember Ataxia UK in your Will, and help secure our future research and support Read more

Minoryx Therapeutics granted FDA Orphan Drug Designation in Friedreich’s Ataxia for new drug leriglitazone

Minoryx Therapeutics has announced that its lead drug candidate, leriglitazone (MIN-102), has been given an Orphan Drug Designation for Friedreich’s Ataxia by the US Food and Drug Administration (FDA).
DWP consultations to ask disabled people how the social security system could better support their needs
Winter Wonderwheels 2019 - Dorney Lake, Windsor

This festive extravaganza is just the challenge to keep you motivated through the colder months!
Very exciting results from Friedreich's ataxia (FA) study

Reata Pharmaceuticals Inc have announced some brilliant news following a study into Friedreich's ataxia treatment.